stockrowFortress Biotech, Inc. (FBIO) vs Spero Therapeutics, Inc. (SPRO)
- Fortress Biotech, Inc. FBIO 1.85 +0.54%
- Spero Therapeutics, Inc. SPRO 1.04 +1.96%
Fortress Biotech, Inc. and Spero Therapeutics, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Spero Therapeutics, Inc. are of similar size ($61.4M and $59.4M). Fortress Biotech, Inc. trades at the lower P/E: 0.6× against 7.4×. Spero Therapeutics, Inc. grew revenue faster over the last twelve months: 37.2% against 15.5%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 21 metrics below, Fortress Biotech, Inc. leads on 11 and Spero Therapeutics, Inc. on 10.
Valuation
Profitability
| Metric | FBIO | SPRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 100.00% | 68.51% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | 19.17% | (51.96%) |
| Return on assets | 43.38% | 12.85% | (46.06%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack